Downregulation of PPARα in monocytes from T2DM patients impairs mitochondrial function, shifts cellular metabolism toward glycolysis, and promotes mtDNA release, thereby activating the cGAS-STING pathway [56]. Here, CGAS is linked to type 2 diabetes mellitus.